Featured Blog
-
December 09, 2024
By MedStar Health Research Institute
This article was written by D. Max Smith, PharmD, BCPS. New pharmacogenetic research answers questions about genetics and dosing of the breast cancer drug ribociclib and opens more discus...
Browse blogs by hospital
Share this
All Blogs
-
November 29, 2016
Nearly 50,000 Americans are diagnosed with cancer of the pancreas each year. In the vast majority of these cases — approximately 95 percent — patients have one specific type of cancer: adenocarcinoma ...
-
November 06, 2016
By MedStar Health Research Institute
Ian M. Brooks, PhD, has joined the MHRI Biostatics and Biomedical Informatics department as the associate director of biomedical informatics. Dr. Brooks was previously faculty in the Department of Pre...
-
November 06, 2016
By MedStar Health Research Institute
Research published in the Journal of Medical Toxicology is working to fill the gap in available information on cardiac arrest outcomes in situations where patients are treated with therapeutic hypothe...
-
November 06, 2016
By MedStar Health Research Institute
Andrew Carter, JD, Contracts and Grants Administrator for the MedStar Georgetown Cancer Institute was awarded the SPIRIT of Excellence Award for this year’s third quarter. The award was present...
-
November 06, 2016
By MedStar Health Research Institute
Congratulations to all researchers who were published in October 2016. There were 48 peer-reviewed studies published in 38 journals that are part of the body of work completed by MedStar Health invest...
-
October 21, 2016Screening tests are a powerful weapon in the fight against breast cancer. Mammography is a breast cancer screening tool used to help doctors pinpoint when a change has occurred in a woman’s breast. In spite of these benefits, and in spite of having health insurance, too many women in Washington, D.C. are forgoing their annual breast cancer mammograms out of fear.